Welcome to our dedicated page for Red Violet SEC filings (Ticker: RDVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Red Violet, Inc.'s SEC filings document the reporting record of an analytics and information solutions company focused on identity intelligence. Form 8-K filings furnish quarterly and annual earnings releases, conference call transcripts and related exhibits covering operating results and financial condition. Other 8-K disclosures address Regulation FD materials, management agreements and capital allocation actions such as the company's stock repurchase program.
Red Violet proxy filings cover public-company governance, executive compensation, equity awards and related compensation disclosures. Together, the filings describe the company's formal reporting around its CORE™ identity intelligence business, governance framework, executive arrangements, capital structure activity and material corporate events.
Red Violet, Inc. director Greg Strakosch received an equity award that increases his direct holdings. On June 4, 2026, he was granted 2,088 restricted stock units (RSUs), which convert into common stock on a one-for-one basis at vesting and were reported as common stock with no purchase price.
The new RSUs vest on the earlier of one year from the grant date or the 2027 annual meeting of stockholders, with potential accelerated vesting under certain conditions. Following this award, Strakosch directly holds 7,955 shares of common stock, reflecting a routine, compensation-related increase in his stake.
Red Violet, Inc. director William Paul Livek received an equity grant of 2,088 restricted stock units (RSUs) on June 4, 2026. These RSUs convert into common stock on a one-for-one basis and vest on the earlier of one year from grant or the 2027 annual stockholder meeting, with potential accelerated vesting in certain cases.
After this grant, Livek holds 20,733 shares and RSUs in total, including several prior RSU awards with scheduled vesting dates through December 1, 2028 and 4,517 vested RSUs for which share delivery has been deferred until separation from service, death, or disability.
Red Violet, Inc. reported results from its 2026 Annual Meeting of Stockholders held on June 3, 2026. Stockholders represented 12,094,664 of the 14,112,391 common shares entitled to vote as of April 9, 2026, providing strong participation.
All five director nominees, including CEO Derek Dubner, were elected to serve until the 2027 annual meeting or until successors are chosen. Stockholders also ratified Grant Thornton LLP as independent registered public accounting firm for the year ending December 31, 2026, with 12,083,156 votes in favor and only 9,602 against.
On an advisory basis, stockholders approved 2025 compensation for named executive officers, with 8,925,718 votes for and 238,311 against, alongside 525,610 abstentions and 2,405,025 broker non-votes. These outcomes indicate general support for the company’s board, auditor selection and executive pay program.
Red Violet, Inc. director Steven D. Rubin reported a stock-based compensation grant. On June 4, 2026, he received 2,179 restricted stock units (RSUs) that convert into common stock on a one-for-one basis and vest on the earlier of one year from grant or the 2027 annual stockholders’ meeting, subject to possible accelerated vesting.
After this award, Rubin directly holds 147,767 shares of common stock, including several prior RSU grants with vesting dates in 2026–2028 and 59,200 vested RSUs for which he has deferred share delivery until separation from the company, death, or disability.
Stanton Lisa M. reported acquisition or exercise transactions in this Form 4 filing.
Red Violet, Inc. director Lisa M. Stanton received an equity award on June 4, 2026. She was granted 2,179 restricted stock units (RSUs), each convertible into one share of common stock, vesting on the earlier of one year from grant or the 2027 annual meeting of stockholders, with potential accelerated vesting under certain conditions.
Following this grant, Stanton directly holds 33,444 shares and RSUs in total, including prior RSU awards with vesting dates in 2026, 2027, and 2028. This is a compensation-related grant, not an open-market share purchase or sale.
Red Violet, Inc. investors file Amendment No. 1 to their Schedule 13D to report that their prior “group” has been dissolved and each now reports holdings individually. As of April 30, 2026, based on 14,108,921 shares outstanding, Derek Dubner beneficially owns 504,420 shares of common stock (3.6%), Daniel MacLachlan 306,049 shares (2.2%), James Patrick Reilly 179,498 shares (1.3%), and Jeffrey Alan Dell 116,249 shares (0.8%). Together they beneficially own 7.8% of Red Violet’s common stock. On June 1, 2026, Dubner, MacLachlan and Reilly each sold 12,000 shares and Dell sold 10,000 shares in open-market transactions at weighted average prices of $57.43 and $57.44 per share. The amendment states that, effective June 1, 2026, they no longer may be deemed a “group” under Section 13(d)(3), each beneficially owns less than 5%, and this filing serves as an exit filing for the prior group.
Red Violet, Inc.'s Chief Information Officer, Jeffrey Alan Dell, sold 10,000 shares of common stock in two open-market transactions on June 1, 2026. The sales covered 5,000 shares at $57.25 and 5,000 shares at $57.62 per share, based on weighted average prices within disclosed ranges.
Following these transactions, he directly holds 155,889 shares of common stock. His position includes 10,000 RSUs granted November 30, 2023, 15,750 RSUs granted November 4, 2024, and 13,890 RSUs granted December 19, 2025, which vest in stages from December 2026 through December 2028.
Red Violet, Inc. director and CEO Derek Dubner reported selling 12,000 shares of common stock in open‑market transactions. The sales occurred on June 1, 2026 at prices of $57.24 and $57.62 per share, according to the Form 4.
After these sales, Dubner directly holds 557,273 shares of Red Violet common stock. He also holds unvested restricted stock units, including 13,333 RSUs granted November 30, 2023 that vest on December 1, 2026, 21,000 RSUs granted November 4, 2024 vesting in 2026 and 2027, and 18,520 RSUs granted December 19, 2025 vesting between 2026 and 2028, each convertible one-for-one into common shares.
Red Violet, Inc. Chief Financial Officer Daniel MacLachlan reported open-market sales of a total of 12,000 shares of common stock on June 1, 2026, executed in two 6,000-share blocks. One block had a weighted average price of $57.62 per share and the other $57.24, each across multiple trades within disclosed price ranges.
After these transactions, MacLachlan holds 358,902 shares directly and 466 shares indirectly through an IRA. His position also includes time-vested restricted stock units of 13,333, 21,000, and 18,520 shares scheduled to vest between December 2026 and December 2028, subject to accelerated vesting in certain circumstances.
Red Violet, Inc. President James Patrick Reilly reported open-market sales of a total of 12,000 shares of common stock on June 1, 2026, executed in two 6,000-share transactions. The shares were sold at prices within disclosed ranges, with weighted average prices of $57.62 and $57.24 per share.
Following these sales, Reilly directly owns 232,351 shares of Red Violet common stock. His reported holdings also include unvested restricted stock units: 13,333 RSUs granted November 30, 2023 that vest on December 1, 2026, 21,000 RSUs granted November 4, 2024 that vest in two equal installments on November 1, 2026 and November 1, 2027, and 18,520 RSUs granted December 19, 2025 that vest in three equal installments on December 1, 2026, December 1, 2027, and December 1, 2028, in each case subject to accelerated vesting under certain circumstances.